Global Recombinant Insulin Lispro Injection Supply, Demand and Key Producers, 2024-2030
Page: 126
Published Date: 11 Feb 2024
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Recombinant Insulin Lispro Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
The main component of recombinant insulin lispro injection is insulin lispro, which is a human insulin analog produced by genetic recombination technology. It is produced by exchanging the 28th and 29th amino acids on the insulin B chain. It is suitable for the need for insulin Adult diabetic patients who maintain euglycemic homeostasis
This report studies the global Recombinant Insulin Lispro Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant Insulin Lispro Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Insulin Lispro Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant Insulin Lispro Injection total production and demand, 2019-2030, (K Units)
Global Recombinant Insulin Lispro Injection total production value, 2019-2030, (USD Million)
Global Recombinant Insulin Lispro Injection production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Recombinant Insulin Lispro Injection consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Recombinant Insulin Lispro Injection domestic production, consumption, key domestic manufacturers and share
Global Recombinant Insulin Lispro Injection production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Recombinant Insulin Lispro Injection production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Recombinant Insulin Lispro Injection production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Recombinant Insulin Lispro Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GT, Tonghua Dongbao Pharmaceutical, Eli Lilly and Company, Novo Nordisk, Pfizer, BI, Sanofi, Takeda Pharmaceutical Company and Wanbang Biopharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Insulin Lispro Injection market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Recombinant Insulin Lispro Injection Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Recombinant Insulin Lispro Injection Market, Segmentation by Type
1ML
3ML
10ML
Global Recombinant Insulin Lispro Injection Market, Segmentation by Application
Hospital
Pharmacy
Companies Profiled:
GT
Tonghua Dongbao Pharmaceutical
Eli Lilly and Company
Novo Nordisk
Pfizer
BI
Sanofi
Takeda Pharmaceutical Company
Wanbang Biopharmaceuticals
United Laboratories
Key Questions Answered
1. How big is the global Recombinant Insulin Lispro Injection market?
2. What is the demand of the global Recombinant Insulin Lispro Injection market?
3. What is the year over year growth of the global Recombinant Insulin Lispro Injection market?
4. What is the production and production value of the global Recombinant Insulin Lispro Injection market?
5. Who are the key producers in the global Recombinant Insulin Lispro Injection market?
Table of Contents
1 Supply Summary
1.1 Recombinant Insulin Lispro Injection Introduction
1.2 World Recombinant Insulin Lispro Injection Supply & Forecast
1.2.1 World Recombinant Insulin Lispro Injection Production Value (2019 & 2023 & 2030)
1.2.2 World Recombinant Insulin Lispro Injection Production (2019-2030)
1.2.3 World Recombinant Insulin Lispro Injection Pricing Trends (2019-2030)
1.3 World Recombinant Insulin Lispro Injection Production by Region (Based on Production Site)
1.3.1 World Recombinant Insulin Lispro Injection Production Value by Region (2019-2030)
1.3.2 World Recombinant Insulin Lispro Injection Production by Region (2019-2030)
1.3.3 World Recombinant Insulin Lispro Injection Average Price by Region (2019-2030)
1.3.4 North America Recombinant Insulin Lispro Injection Production (2019-2030)
1.3.5 Europe Recombinant Insulin Lispro Injection Production (2019-2030)
1.3.6 China Recombinant Insulin Lispro Injection Production (2019-2030)
1.3.7 Japan Recombinant Insulin Lispro Injection Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Insulin Lispro Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Insulin Lispro Injection Major Market Trends
2.1 World Recombinant Insulin Lispro Injection Demand (2019-2030)
2.2 World Recombinant Insulin Lispro Injection Consumption by Region
2.2.1 World Recombinant Insulin Lispro Injection Consumption by Region (2019-2024)
2.2.2 World Recombinant Insulin Lispro Injection Consumption Forecast by Region (2025-2030)
2.3 United States Recombinant Insulin Lispro Injection Consumption (2019-2030)
2.4 China Recombinant Insulin Lispro Injection Consumption (2019-2030)
2.5 Europe Recombinant Insulin Lispro Injection Consumption (2019-2030)
2.6 Japan Recombinant Insulin Lispro Injection Consumption (2019-2030)
2.7 South Korea Recombinant Insulin Lispro Injection Consumption (2019-2030)
2.8 ASEAN Recombinant Insulin Lispro Injection Consumption (2019-2030)
2.9 India Recombinant Insulin Lispro Injection Consumption (2019-2030)
3.1 World Recombinant Insulin Lispro Injection Production Value by Manufacturer (2019-2024)
3.2 World Recombinant Insulin Lispro Injection Production by Manufacturer (2019-2024)
3.3 World Recombinant Insulin Lispro Injection Average Price by Manufacturer (2019-2024)
3.4 Recombinant Insulin Lispro Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Insulin Lispro Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Insulin Lispro Injection in 2023
3.5.3 Global Concentration Ratios (CR8) for Recombinant Insulin Lispro Injection in 2023
3.6 Recombinant Insulin Lispro Injection Market: Overall Company Footprint Analysis
3.6.1 Recombinant Insulin Lispro Injection Market: Region Footprint
3.6.2 Recombinant Insulin Lispro Injection Market: Company Product Type Footprint
3.6.3 Recombinant Insulin Lispro Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Recombinant Insulin Lispro Injection Production Value Comparison
4.1.1 United States VS China: Recombinant Insulin Lispro Injection Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Recombinant Insulin Lispro Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Recombinant Insulin Lispro Injection Production Comparison
4.2.1 United States VS China: Recombinant Insulin Lispro Injection Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Recombinant Insulin Lispro Injection Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Recombinant Insulin Lispro Injection Consumption Comparison
4.3.1 United States VS China: Recombinant Insulin Lispro Injection Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Recombinant Insulin Lispro Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Recombinant Insulin Lispro Injection Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Recombinant Insulin Lispro Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Insulin Lispro Injection Production Value (2019-2024)
4.4.3 United States Based Manufacturers Recombinant Insulin Lispro Injection Production (2019-2024)
4.5 China Based Recombinant Insulin Lispro Injection Manufacturers and Market Share
4.5.1 China Based Recombinant Insulin Lispro Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Insulin Lispro Injection Production Value (2019-2024)
4.5.3 China Based Manufacturers Recombinant Insulin Lispro Injection Production (2019-2024)
4.6 Rest of World Based Recombinant Insulin Lispro Injection Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Recombinant Insulin Lispro Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Insulin Lispro Injection Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Recombinant Insulin Lispro Injection Production (2019-2024)
5.1 World Recombinant Insulin Lispro Injection Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 1ML
5.2.2 3ML
5.2.3 10ML
5.3 Market Segment by Type
5.3.1 World Recombinant Insulin Lispro Injection Production by Type (2019-2030)
5.3.2 World Recombinant Insulin Lispro Injection Production Value by Type (2019-2030)
5.3.3 World Recombinant Insulin Lispro Injection Average Price by Type (2019-2030)
6.1 World Recombinant Insulin Lispro Injection Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Pharmacy
6.3 Market Segment by Application
6.3.1 World Recombinant Insulin Lispro Injection Production by Application (2019-2030)
6.3.2 World Recombinant Insulin Lispro Injection Production Value by Application (2019-2030)
6.3.3 World Recombinant Insulin Lispro Injection Average Price by Application (2019-2030)
7.1 GT
7.1.1 GT Details
7.1.2 GT Major Business
7.1.3 GT Recombinant Insulin Lispro Injection Product and Services
7.1.4 GT Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 GT Recent Developments/Updates
7.1.6 GT Competitive Strengths & Weaknesses
7.2 Tonghua Dongbao Pharmaceutical
7.2.1 Tonghua Dongbao Pharmaceutical Details
7.2.2 Tonghua Dongbao Pharmaceutical Major Business
7.2.3 Tonghua Dongbao Pharmaceutical Recombinant Insulin Lispro Injection Product and Services
7.2.4 Tonghua Dongbao Pharmaceutical Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
7.2.6 Tonghua Dongbao Pharmaceutical Competitive Strengths & Weaknesses
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Details
7.3.2 Eli Lilly and Company Major Business
7.3.3 Eli Lilly and Company Recombinant Insulin Lispro Injection Product and Services
7.3.4 Eli Lilly and Company Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Eli Lilly and Company Recent Developments/Updates
7.3.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.4 Novo Nordisk
7.4.1 Novo Nordisk Details
7.4.2 Novo Nordisk Major Business
7.4.3 Novo Nordisk Recombinant Insulin Lispro Injection Product and Services
7.4.4 Novo Nordisk Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Novo Nordisk Recent Developments/Updates
7.4.6 Novo Nordisk Competitive Strengths & Weaknesses
7.5 Pfizer
7.5.1 Pfizer Details
7.5.2 Pfizer Major Business
7.5.3 Pfizer Recombinant Insulin Lispro Injection Product and Services
7.5.4 Pfizer Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Pfizer Recent Developments/Updates
7.5.6 Pfizer Competitive Strengths & Weaknesses
7.6 BI
7.6.1 BI Details
7.6.2 BI Major Business
7.6.3 BI Recombinant Insulin Lispro Injection Product and Services
7.6.4 BI Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 BI Recent Developments/Updates
7.6.6 BI Competitive Strengths & Weaknesses
7.7 Sanofi
7.7.1 Sanofi Details
7.7.2 Sanofi Major Business
7.7.3 Sanofi Recombinant Insulin Lispro Injection Product and Services
7.7.4 Sanofi Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Sanofi Recent Developments/Updates
7.7.6 Sanofi Competitive Strengths & Weaknesses
7.8 Takeda Pharmaceutical Company
7.8.1 Takeda Pharmaceutical Company Details
7.8.2 Takeda Pharmaceutical Company Major Business
7.8.3 Takeda Pharmaceutical Company Recombinant Insulin Lispro Injection Product and Services
7.8.4 Takeda Pharmaceutical Company Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Takeda Pharmaceutical Company Recent Developments/Updates
7.8.6 Takeda Pharmaceutical Company Competitive Strengths & Weaknesses
7.9 Wanbang Biopharmaceuticals
7.9.1 Wanbang Biopharmaceuticals Details
7.9.2 Wanbang Biopharmaceuticals Major Business
7.9.3 Wanbang Biopharmaceuticals Recombinant Insulin Lispro Injection Product and Services
7.9.4 Wanbang Biopharmaceuticals Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Wanbang Biopharmaceuticals Recent Developments/Updates
7.9.6 Wanbang Biopharmaceuticals Competitive Strengths & Weaknesses
7.10 United Laboratories
7.10.1 United Laboratories Details
7.10.2 United Laboratories Major Business
7.10.3 United Laboratories Recombinant Insulin Lispro Injection Product and Services
7.10.4 United Laboratories Recombinant Insulin Lispro Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 United Laboratories Recent Developments/Updates
7.10.6 United Laboratories Competitive Strengths & Weaknesses
8.1 Recombinant Insulin Lispro Injection Industry Chain
8.2 Recombinant Insulin Lispro Injection Upstream Analysis
8.2.1 Recombinant Insulin Lispro Injection Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Insulin Lispro Injection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Insulin Lispro Injection Production Mode
8.6 Recombinant Insulin Lispro Injection Procurement Model
8.7 Recombinant Insulin Lispro Injection Industry Sales Model and Sales Channels
8.7.1 Recombinant Insulin Lispro Injection Sales Model
8.7.2 Recombinant Insulin Lispro Injection Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Recombinant Insulin Lispro Injection Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Recombinant Insulin Lispro Injection Production Value by Region (2019-2024) & (USD Million)
Table 3. World Recombinant Insulin Lispro Injection Production Value by Region (2025-2030) & (USD Million)
Table 4. World Recombinant Insulin Lispro Injection Production Value Market Share by Region (2019-2024)
Table 5. World Recombinant Insulin Lispro Injection Production Value Market Share by Region (2025-2030)
Table 6. World Recombinant Insulin Lispro Injection Production by Region (2019-2024) & (K Units)
Table 7. World Recombinant Insulin Lispro Injection Production by Region (2025-2030) & (K Units)
Table 8. World Recombinant Insulin Lispro Injection Production Market Share by Region (2019-2024)
Table 9. World Recombinant Insulin Lispro Injection Production Market Share by Region (2025-2030)
Table 10. World Recombinant Insulin Lispro Injection Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Recombinant Insulin Lispro Injection Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Recombinant Insulin Lispro Injection Major Market Trends
Table 13. World Recombinant Insulin Lispro Injection Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Recombinant Insulin Lispro Injection Consumption by Region (2019-2024) & (K Units)
Table 15. World Recombinant Insulin Lispro Injection Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Recombinant Insulin Lispro Injection Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Insulin Lispro Injection Producers in 2023
Table 18. World Recombinant Insulin Lispro Injection Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Recombinant Insulin Lispro Injection Producers in 2023
Table 20. World Recombinant Insulin Lispro Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Recombinant Insulin Lispro Injection Company Evaluation Quadrant
Table 22. World Recombinant Insulin Lispro Injection Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Recombinant Insulin Lispro Injection Production Site of Key Manufacturer
Table 24. Recombinant Insulin Lispro Injection Market: Company Product Type Footprint
Table 25. Recombinant Insulin Lispro Injection Market: Company Product Application Footprint
Table 26. Recombinant Insulin Lispro Injection Competitive Factors
Table 27. Recombinant Insulin Lispro Injection New Entrant and Capacity Expansion Plans
Table 28. Recombinant Insulin Lispro Injection Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Insulin Lispro Injection Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Recombinant Insulin Lispro Injection Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Recombinant Insulin Lispro Injection Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Recombinant Insulin Lispro Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Insulin Lispro Injection Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Insulin Lispro Injection Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Recombinant Insulin Lispro Injection Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Recombinant Insulin Lispro Injection Production Market Share (2019-2024)
Table 37. China Based Recombinant Insulin Lispro Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Insulin Lispro Injection Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Recombinant Insulin Lispro Injection Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Recombinant Insulin Lispro Injection Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Recombinant Insulin Lispro Injection Production Market Share (2019-2024)
Table 42. Rest of World Based Recombinant Insulin Lispro Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Insulin Lispro Injection Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Insulin Lispro Injection Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Recombinant Insulin Lispro Injection Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Recombinant Insulin Lispro Injection Production Market Share (2019-2024)
Table 47. World Recombinant Insulin Lispro Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Recombinant Insulin Lispro Injection Production by Type (2019-2024) & (K Units)
Table 49. World Recombinant Insulin Lispro Injection Production by Type (2025-2030) & (K Units)
Table 50. World Recombinant Insulin Lispro Injection Production Value by Type (2019-2024) & (USD Million)
Table 51. World Recombinant Insulin Lispro Injection Production Value by Type (2025-2030) & (USD Million)
Table 52. World Recombinant Insulin Lispro Injection Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Recombinant Insulin Lispro Injection Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Recombinant Insulin Lispro Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Recombinant Insulin Lispro Injection Production by Application (2019-2024) & (K Units)
Table 56. World Recombinant Insulin Lispro Injection Production by Application (2025-2030) & (K Units)
Table 57. World Recombinant Insulin Lispro Injection Production Value by Application (2019-2024) & (USD Million)
Table 58. World Recombinant Insulin Lispro Injection Production Value by Application (2025-2030) & (USD Million)
Table 59. World Recombinant Insulin Lispro Injection Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Recombinant Insulin Lispro Injection Average Price by Application (2025-2030) & (US$/Unit)
Table 61. GT Basic Information, Manufacturing Base and Competitors
Table 62. GT Major Business
Table 63. GT Recombinant Insulin Lispro Injection Product and Services
Table 64. GT Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. GT Recent Developments/Updates
Table 66. GT Competitive Strengths & Weaknesses
Table 67. Tonghua Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Tonghua Dongbao Pharmaceutical Major Business
Table 69. Tonghua Dongbao Pharmaceutical Recombinant Insulin Lispro Injection Product and Services
Table 70. Tonghua Dongbao Pharmaceutical Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 72. Tonghua Dongbao Pharmaceutical Competitive Strengths & Weaknesses
Table 73. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 74. Eli Lilly and Company Major Business
Table 75. Eli Lilly and Company Recombinant Insulin Lispro Injection Product and Services
Table 76. Eli Lilly and Company Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Eli Lilly and Company Recent Developments/Updates
Table 78. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 79. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 80. Novo Nordisk Major Business
Table 81. Novo Nordisk Recombinant Insulin Lispro Injection Product and Services
Table 82. Novo Nordisk Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Novo Nordisk Recent Developments/Updates
Table 84. Novo Nordisk Competitive Strengths & Weaknesses
Table 85. Pfizer Basic Information, Manufacturing Base and Competitors
Table 86. Pfizer Major Business
Table 87. Pfizer Recombinant Insulin Lispro Injection Product and Services
Table 88. Pfizer Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Pfizer Recent Developments/Updates
Table 90. Pfizer Competitive Strengths & Weaknesses
Table 91. BI Basic Information, Manufacturing Base and Competitors
Table 92. BI Major Business
Table 93. BI Recombinant Insulin Lispro Injection Product and Services
Table 94. BI Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. BI Recent Developments/Updates
Table 96. BI Competitive Strengths & Weaknesses
Table 97. Sanofi Basic Information, Manufacturing Base and Competitors
Table 98. Sanofi Major Business
Table 99. Sanofi Recombinant Insulin Lispro Injection Product and Services
Table 100. Sanofi Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Sanofi Recent Developments/Updates
Table 102. Sanofi Competitive Strengths & Weaknesses
Table 103. Takeda Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 104. Takeda Pharmaceutical Company Major Business
Table 105. Takeda Pharmaceutical Company Recombinant Insulin Lispro Injection Product and Services
Table 106. Takeda Pharmaceutical Company Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Takeda Pharmaceutical Company Recent Developments/Updates
Table 108. Takeda Pharmaceutical Company Competitive Strengths & Weaknesses
Table 109. Wanbang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 110. Wanbang Biopharmaceuticals Major Business
Table 111. Wanbang Biopharmaceuticals Recombinant Insulin Lispro Injection Product and Services
Table 112. Wanbang Biopharmaceuticals Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Wanbang Biopharmaceuticals Recent Developments/Updates
Table 114. United Laboratories Basic Information, Manufacturing Base and Competitors
Table 115. United Laboratories Major Business
Table 116. United Laboratories Recombinant Insulin Lispro Injection Product and Services
Table 117. United Laboratories Recombinant Insulin Lispro Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 118. Global Key Players of Recombinant Insulin Lispro Injection Upstream (Raw Materials)
Table 119. Recombinant Insulin Lispro Injection Typical Customers
Table 120. Recombinant Insulin Lispro Injection Typical Distributors
List of Figure
Figure 1. Recombinant Insulin Lispro Injection Picture
Figure 2. World Recombinant Insulin Lispro Injection Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Recombinant Insulin Lispro Injection Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Recombinant Insulin Lispro Injection Production (2019-2030) & (K Units)
Figure 5. World Recombinant Insulin Lispro Injection Average Price (2019-2030) & (US$/Unit)
Figure 6. World Recombinant Insulin Lispro Injection Production Value Market Share by Region (2019-2030)
Figure 7. World Recombinant Insulin Lispro Injection Production Market Share by Region (2019-2030)
Figure 8. North America Recombinant Insulin Lispro Injection Production (2019-2030) & (K Units)
Figure 9. Europe Recombinant Insulin Lispro Injection Production (2019-2030) & (K Units)
Figure 10. China Recombinant Insulin Lispro Injection Production (2019-2030) & (K Units)
Figure 11. Japan Recombinant Insulin Lispro Injection Production (2019-2030) & (K Units)
Figure 12. Recombinant Insulin Lispro Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Insulin Lispro Injection Consumption (2019-2030) & (K Units)
Figure 15. World Recombinant Insulin Lispro Injection Consumption Market Share by Region (2019-2030)
Figure 16. United States Recombinant Insulin Lispro Injection Consumption (2019-2030) & (K Units)
Figure 17. China Recombinant Insulin Lispro Injection Consumption (2019-2030) & (K Units)
Figure 18. Europe Recombinant Insulin Lispro Injection Consumption (2019-2030) & (K Units)
Figure 19. Japan Recombinant Insulin Lispro Injection Consumption (2019-2030) & (K Units)
Figure 20. South Korea Recombinant Insulin Lispro Injection Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Recombinant Insulin Lispro Injection Consumption (2019-2030) & (K Units)
Figure 22. India Recombinant Insulin Lispro Injection Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Recombinant Insulin Lispro Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Insulin Lispro Injection Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Insulin Lispro Injection Markets in 2023
Figure 26. United States VS China: Recombinant Insulin Lispro Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Recombinant Insulin Lispro Injection Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Recombinant Insulin Lispro Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Recombinant Insulin Lispro Injection Production Market Share 2023
Figure 30. China Based Manufacturers Recombinant Insulin Lispro Injection Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Recombinant Insulin Lispro Injection Production Market Share 2023
Figure 32. World Recombinant Insulin Lispro Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Recombinant Insulin Lispro Injection Production Value Market Share by Type in 2023
Figure 34. 1ML
Figure 35. 3ML
Figure 36. 10ML
Figure 37. World Recombinant Insulin Lispro Injection Production Market Share by Type (2019-2030)
Figure 38. World Recombinant Insulin Lispro Injection Production Value Market Share by Type (2019-2030)
Figure 39. World Recombinant Insulin Lispro Injection Average Price by Type (2019-2030) & (US$/Unit)
Figure 40. World Recombinant Insulin Lispro Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World Recombinant Insulin Lispro Injection Production Value Market Share by Application in 2023
Figure 42. Hospital
Figure 43. Pharmacy
Figure 44. World Recombinant Insulin Lispro Injection Production Market Share by Application (2019-2030)
Figure 45. World Recombinant Insulin Lispro Injection Production Value Market Share by Application (2019-2030)
Figure 46. World Recombinant Insulin Lispro Injection Average Price by Application (2019-2030) & (US$/Unit)
Figure 47. Recombinant Insulin Lispro Injection Industry Chain
Figure 48. Recombinant Insulin Lispro Injection Procurement Model
Figure 49. Recombinant Insulin Lispro Injection Sales Model
Figure 50. Recombinant Insulin Lispro Injection Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
GT Tonghua Dongbao Pharmaceutical Eli Lilly and Company Novo Nordisk Pfizer BI Sanofi Takeda Pharmaceutical Company Wanbang Biopharmaceuticals United Laboratories
Related Reports
13 Jan 2023
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
